Health Care
  • Pfizer keen to engage with AstraZeneca board

    Pfizer keen to engage with AstraZeneca board

    By Reuters

    LONDON (Reuters) - U.S. drugmaker Pfizer kept up the pressure on bid target AstraZeneca on Tuesday, saying its offer represented compelling value for a company which would otherwise face challenges...

  • U.S. confirms second case of MERS

    U.S. confirms second case of MERS

    By Julie Steenhuysen and Barbara Liston, Reuters

    CHICAGO/ORLANDO (Reuters) - U.S. health officials confirmed the country's second case of MERS, a deadly virus first discovered in the Middle East, and said the patient was in good condition in an...

  • Boehner Aide Flip-Flops on Obamacare

    When people talk about the revolving door in Washington, they’re usually referring to legislators and their aides already friendly to a particular cause or industry leaving Capitol Hill to go work in...

  • Democrats struggle to win over skeptical Americans on Obamacare

    Democrats struggle to win over skeptical Americans on Obamacare

    By Susan Cornwell, Reuters

    SOMERSWORTH, New Hampshire (Reuters) - Barack Obama and his Democratic allies in the Congress have grown more confident in recent months about their ability to use the president's signature...

  • UK labs play shrinking role in AstraZeneca drug portfolio

    UK labs play shrinking role in AstraZeneca drug portfolio

    By Ben Hirschler, Reuters

    LONDON (Reuters) - How British is AstraZeneca? With a French chief executive, Swedish chairman, 40 percent of its sales in the United States and 87 percent of its staff overseas, the answer is not...